Related Experiment Video
Updated: Jul 11, 2025

Lung CT Segmentation to Identify Consolidations and Ground Glass Areas for Quantitative Assesment of SARS-CoV Pneumonia
Published on: December 19, 2020
[Covid19 in a polypathological subject]
Abdramane Traoré1, Djenebou Traoré2, Hamsatou Cisse1
1Service de Médecine du CHU Sidy Bocar Sall Kati.
Insights
This case study highlights a severe COVID-19 infection in a 71-year-old patient with multiple comorbidities. Despite intensive treatment, including mechanical ventilation and hydroxychloroquine, the patient experienced an unfavorable outcome, emphasizing the serious nature of SARS-CoV-2.
Area of Science:
- Virology
- Infectious Diseases
- Critical Care Medicine
Context:
- The emergence of SARS-CoV-2 (severe acute respiratory syndrome coronavirus 2) in late 2019 led to the COVID-19 pandemic.
- COVID-19, a significant respiratory illness, presents a global health challenge.
Purpose:
- To present a clinical case of a severe COVID-19 infection in an elderly patient.
- To detail the clinical presentation, management, and outcome of a critical COVID-19 case.
Summary:
- A 71-year-old female presented with dyspnea, cough, fever, and other symptoms consistent with severe COVID-19.
- Physical examination revealed respiratory distress, hypoxia, and crackles, necessitating intubation and mechanical ventilation.
- Treatment included hydroxychloroquine and broad-spectrum antibiotics; however, the patient's condition deteriorated, leading to death.
Impact:
- This case underscores the critical illness potential of COVID-19, particularly in elderly patients with comorbidities.
- The unfavorable outcome highlights the challenges in managing severe SARS-CoV-2 infections and the need for effective therapeutic strategies.
Abstract:
In December 2019, an outbreak of pneumonia due to the 2019 novel coronavirus, SARS-CoV-2 (severe acute respiratory syndrome coronavirus 2), broke out in Wuhan, Hubei, China. This betacoronavirus causes a sometimes severe respiratory pathology, named COVID-19 by the World Health Organization (WHO). The WHO declared COVID-19 as a pandemic in March 2020. It is Mrs. RM, 71 years old of French nationality who consults for dyspnea on exertion for 8 days associated with a dry cough, an intermittent fever with periods of spontaneous remissions, a chest pain accentuated by the efforts of cough, a physical asthenia, non-selective anorexia, diarrhea and vomiting. The physical examination found respiratory distress with 72% desaturation in ambient air, requiring oxygen-requisition with 96% oxygen saturation under 10 liters with no sign of respiratory struggle; crackling rales with 2 more predominant lung fields on the right, mucocutaneous jaundice, edema of the lower limbs. The management was intubation upon admission with mechanical ventilation, oral administration of hydroxychloroquine 200 mg due to 2 tablets morning and evening for 24 hours then 1 tablet morning and evening for 04 days, antibiotic therapy based on ceftriaxone 1g morning and evening was implemented, in the absence of bacteriological evidence. The course was unfavorable with a death with the absence of clinical improvement and a very precarious hematosis escaping any treatment alternative.
Conclusion:
Covid19 is a very serious virus with a poor prognosis in multiple pathological patients.
More Related Videos
Related Concept Videos
Factors Affecting the Risk of Infection
The integrity and count of the white blood cells help the body resist pathogens and fight infection. When impaired, it reduces the body's resistance to pathogens. The acidic pH levels of the gastrointestinal, genitourinary tracts, and skin...
Controls in Experiments

